Targeting the Untargetable: Predicting Pramlintide Resistance Using a Neural Network Based Cellular Automata
Eunjung Kim, Ryan Schenck, Jeffrey West, William Cross, Valerie Harris, Joseph McKenna, Heyrim Cho, Elizabeth Coker, Steven Lee-Kramer Kenneth Y. Tsai, Elsa R. Flores, Chandler Gatenbee
This paper develops a hybrid neural network/agent-based model to predict Pramlintide resistance in cutaneous squamous cell carcinoma and enable personalized treatment decisions.
bioRxiv · Nov 11, 2017 · PreprintCancer Biology